Lista de obras - Yu-yun Shao - Dominio Público Uruguay

A pilot study of hepatic arterial infusion of chemotherapy for patients with advanced hepatocellular carcinoma who have failed anti-angiogenic therapy

artículo científico publicado en 2013

Bevacizumab with erlotinib as first-line therapy in Asian patients with advanced hepatocellular carcinoma: a multicenter phase II study

artículo científico publicado en 2013

Characteristics and risk factors of oxaliplatin-related hypersensitivity reactions

artículo científico publicado en 2010

Clinical Activity of Metronomic Chemotherapy in Liver Cancers

Comparative effectiveness of first-line platinum-based chemotherapy regimens for advanced lung squamous cell carcinoma

artículo científico publicado en 2014

Comparison of gefitinib and erlotinib efficacies as third-line therapy for advanced non-small-cell lung cancer

artículo científico publicado en 2012

Cyclin E1 Inhibition can Overcome Sorafenib Resistance in Hepatocellular Carcinoma Cells Through Mcl-1 Suppression.

artículo científico publicado en 2015

Cytotoxic Chemotherapy as First-Line Therapy for Advanced Non-Small-Cell Lung Cancer in Taiwan: Daily Practice

scientific article published on 07 July 2016

Diabetes mellitus is associated with increased mortality in patients receiving curative therapy for hepatocellular carcinoma

artículo científico publicado en 2012

Differential Organ-Specific Tumor Response to Immune Checkpoint Inhibitors in Hepatocellular Carcinoma

scientific article published on 06 August 2019

Do-not-resuscitate consent signed by patients indicates a more favorable quality of end-of-life care for patients with advanced cancer

artículo científico publicado en 2016

Early alpha-fetoprotein response predicts treatment efficacy of antiangiogenic systemic therapy in patients with advanced hepatocellular carcinoma

artículo científico publicado en 2010

Early alpha-foetoprotein response associated with treatment efficacy of immune checkpoint inhibitors for advanced hepatocellular carcinoma

artículo científico publicado en 2019

Efficacy, Safety, and Potential Biomarkers of Thalidomide plus Metronomic Chemotherapy for Advanced Hepatocellular Carcinoma

Factors impacting prognosis prediction in BCLC stage C and Child-Pugh class A hepatocellular carcinoma patients in prospective clinical trials of systemic therapy

artículo científico publicado en 2012

Hepatic arterial infusion of chemotherapy for advanced hepatocellular carcinoma

scientific article published on June 2010

High Serum Transforming Growth Factor-β1 Levels Predict Outcome in Hepatocellular Carcinoma Patients Treated with Sorafenib

artículo científico publicado en 2015

High circulating endothelial progenitor levels associated with poor survival of advanced hepatocellular carcinoma patients receiving sorafenib combined with metronomic chemotherapy.

artículo científico publicado en 2011

High plasma interleukin-6 levels associated with poor prognosis of patients with advanced hepatocellular carcinoma

artículo científico publicado en 2017

Hospital volume of percutaneous radiofrequency ablation is closely associated with treatment outcomes for patients with hepatocellular carcinoma.

artículo científico publicado en 2012

Increasing Incidence of Brain Metastasis in Patients with Advanced Hepatocellular Carcinoma in the Era of Antiangiogenic Targeted Therapy ⬇️

artículo científico publicado el 6 de enero de 2011

Inhibition of the Wnt/β-catenin signaling pathway improves the anti-tumor effects of sorafenib against hepatocellular carcinoma

artículo científico publicado en 2016

Key opioid prescription concerns in cancer patients: A nationwide study.

artículo científico publicado en 2016

Long-term disease-free survival achieved by anti-angiogenic therapy plus surgery in a hepatocellular carcinoma patient with extensive liver involvement and lung metastases

article published in 2014

Modern prospection for hepatic arterial infusion chemotherapy in malignancies with liver metastases

artículo científico publicado en 2013

Modified CLIP with objective liver reserve assessment retains prognosis prediction for patients with advanced hepatocellular carcinoma

artículo científico publicado en 2016

National Policies Fostering Hospice Care Increased Hospice Utilization and Reduced the Invasiveness of End-of-Life Care for Cancer Patients

artículo científico publicado en 2017

Phase II study of combining sorafenib with metronomic tegafur/uracil for advanced hepatocellular carcinoma

artículo científico publicado en 2010

Phase Ib study of codrituzumab in combination with sorafenib in patients with non-curable advanced hepatocellular carcinoma (HCC)

artículo científico publicado en 2017

Pleural metastases as a unique entity with dismal outcome of head and neck squamous cell carcinoma ⬇️

artículo científico publicado el 23 de agosto de 2010

Potent Activity of Composite Cyclin Dependent Kinase Inhibition against Hepatocellular Carcinoma

artículo científico publicado en 2019

Predictive and Prognostic Values of Tau and ERCC1 in Advanced Breast Cancer Patients Treated with Paclitaxel and Cisplatin

artículo científico publicado en 2010

Predictive biomarkers of sorafenib efficacy in advanced hepatocellular carcinoma: Are we getting there?

artículo científico publicado en 2015

Primary tumor site is a useful predictor of cetuximab efficacy in the third-line or salvage treatment of KRAS wild-type (exon 2 non-mutant) metastatic colorectal cancer: a nationwide cohort study

artículo científico publicado en 2016

Prognosis of advanced hepatocellular carcinoma patients enrolled in clinical trials can be classified by current staging systems.

artículo científico publicado en 2012

Radiofrequency ablation is superior to ethanol injection in early-stage hepatocellular carcinoma irrespective of tumor size

artículo científico publicado en 2013

Satisfaction with pain management and impact of pain on quality of life in cancer patients

artículo científico publicado en 2018

Serum Insulin-Like Growth Factor-1 Levels Predict Outcomes of Patients with Advanced Hepatocellular Carcinoma Receiving Antiangiogenic Therapy

artículo científico publicado en 2012

Solving the deficit of cancer pain management skills by education programs

scientific article published on 11 August 2020

Statin Use Is Associated With Improved Prognosis of Colorectal Cancer in Taiwan

artículo científico publicado en 2015

Survival following surgery with or without adjuvant chemotherapy for stage I-IIIA non-small cell lung cancer: an east asian population-based study

artículo científico publicado en 2012

Survival of patients with small cell lung carcinoma in Taiwan

artículo científico publicado en 2012

The Prognostic Impact of Type 2 Diabetes Mellitus on Early Cervical Cancer in Asia

artículo científico publicado en 2015

The germline BIM deletion polymorphism is not associated with the treatment efficacy of sorafenib in patients with advanced hepatocellular carcinoma

artículo científico publicado en 2013

The impact of diabetes mellitus on prognosis of early breast cancer in Asia

artículo científico publicado en 2012

Treatment efficacy differences of sorafenib for advanced hepatocellular carcinoma: a meta-analysis of randomized clinical trials

artículo científico publicado en 2015

Type 2 diabetes mellitus is associated with increased mortality in Chinese patients receiving curative surgery for colon cancer

artículo científico publicado en 2014

Young patients with colorectal cancer have increased risk of second primary cancers

artículo científico publicado en 2015

β-catenin (CTNNB1) mutations are not associated with prognosis in advanced hepatocellular carcinoma

artículo científico publicado en 2014

Lista de obras de Yu-yun Shao

A pilot study of hepatic arterial infusion of chemotherapy for patients with advanced hepatocellular carcinoma who have failed anti-angiogenic therapy

Bevacizumab with erlotinib as first-line therapy in Asian patients with advanced hepatocellular carcinoma: a multicenter phase II study

Characteristics and risk factors of oxaliplatin-related hypersensitivity reactions

Clinical Activity of Metronomic Chemotherapy in Liver Cancers

Comparative effectiveness of first-line platinum-based chemotherapy regimens for advanced lung squamous cell carcinoma

Comparison of gefitinib and erlotinib efficacies as third-line therapy for advanced non-small-cell lung cancer

Cyclin E1 Inhibition can Overcome Sorafenib Resistance in Hepatocellular Carcinoma Cells Through Mcl-1 Suppression.

Cytotoxic Chemotherapy as First-Line Therapy for Advanced Non-Small-Cell Lung Cancer in Taiwan: Daily Practice

Diabetes mellitus is associated with increased mortality in patients receiving curative therapy for hepatocellular carcinoma

Differential Organ-Specific Tumor Response to Immune Checkpoint Inhibitors in Hepatocellular Carcinoma

Do-not-resuscitate consent signed by patients indicates a more favorable quality of end-of-life care for patients with advanced cancer

Early alpha-fetoprotein response predicts treatment efficacy of antiangiogenic systemic therapy in patients with advanced hepatocellular carcinoma

Early alpha-foetoprotein response associated with treatment efficacy of immune checkpoint inhibitors for advanced hepatocellular carcinoma

Efficacy, Safety, and Potential Biomarkers of Thalidomide plus Metronomic Chemotherapy for Advanced Hepatocellular Carcinoma

Factors impacting prognosis prediction in BCLC stage C and Child-Pugh class A hepatocellular carcinoma patients in prospective clinical trials of systemic therapy

Hepatic arterial infusion of chemotherapy for advanced hepatocellular carcinoma

High Serum Transforming Growth Factor-β1 Levels Predict Outcome in Hepatocellular Carcinoma Patients Treated with Sorafenib

High circulating endothelial progenitor levels associated with poor survival of advanced hepatocellular carcinoma patients receiving sorafenib combined with metronomic chemotherapy.

High plasma interleukin-6 levels associated with poor prognosis of patients with advanced hepatocellular carcinoma

Hospital volume of percutaneous radiofrequency ablation is closely associated with treatment outcomes for patients with hepatocellular carcinoma.

Increasing Incidence of Brain Metastasis in Patients with Advanced Hepatocellular Carcinoma in the Era of Antiangiogenic Targeted Therapy ⬇️

Inhibition of the Wnt/β-catenin signaling pathway improves the anti-tumor effects of sorafenib against hepatocellular carcinoma

Key opioid prescription concerns in cancer patients: A nationwide study.

Long-term disease-free survival achieved by anti-angiogenic therapy plus surgery in a hepatocellular carcinoma patient with extensive liver involvement and lung metastases

Modern prospection for hepatic arterial infusion chemotherapy in malignancies with liver metastases

Modified CLIP with objective liver reserve assessment retains prognosis prediction for patients with advanced hepatocellular carcinoma

National Policies Fostering Hospice Care Increased Hospice Utilization and Reduced the Invasiveness of End-of-Life Care for Cancer Patients

Phase II study of combining sorafenib with metronomic tegafur/uracil for advanced hepatocellular carcinoma

Phase Ib study of codrituzumab in combination with sorafenib in patients with non-curable advanced hepatocellular carcinoma (HCC)

Pleural metastases as a unique entity with dismal outcome of head and neck squamous cell carcinoma ⬇️

Potent Activity of Composite Cyclin Dependent Kinase Inhibition against Hepatocellular Carcinoma

Predictive and Prognostic Values of Tau and ERCC1 in Advanced Breast Cancer Patients Treated with Paclitaxel and Cisplatin

Predictive biomarkers of sorafenib efficacy in advanced hepatocellular carcinoma: Are we getting there?

Primary tumor site is a useful predictor of cetuximab efficacy in the third-line or salvage treatment of KRAS wild-type (exon 2 non-mutant) metastatic colorectal cancer: a nationwide cohort study

Prognosis of advanced hepatocellular carcinoma patients enrolled in clinical trials can be classified by current staging systems.

Radiofrequency ablation is superior to ethanol injection in early-stage hepatocellular carcinoma irrespective of tumor size

Satisfaction with pain management and impact of pain on quality of life in cancer patients

Serum Insulin-Like Growth Factor-1 Levels Predict Outcomes of Patients with Advanced Hepatocellular Carcinoma Receiving Antiangiogenic Therapy

Solving the deficit of cancer pain management skills by education programs

Statin Use Is Associated With Improved Prognosis of Colorectal Cancer in Taiwan

Survival following surgery with or without adjuvant chemotherapy for stage I-IIIA non-small cell lung cancer: an east asian population-based study

Survival of patients with small cell lung carcinoma in Taiwan

The Prognostic Impact of Type 2 Diabetes Mellitus on Early Cervical Cancer in Asia

The germline BIM deletion polymorphism is not associated with the treatment efficacy of sorafenib in patients with advanced hepatocellular carcinoma

The impact of diabetes mellitus on prognosis of early breast cancer in Asia

Treatment efficacy differences of sorafenib for advanced hepatocellular carcinoma: a meta-analysis of randomized clinical trials

Type 2 diabetes mellitus is associated with increased mortality in Chinese patients receiving curative surgery for colon cancer

Young patients with colorectal cancer have increased risk of second primary cancers

β-catenin (CTNNB1) mutations are not associated with prognosis in advanced hepatocellular carcinoma